Fortitude Family Office’s TriSalus Life Sciences TLSI Stock Holding History

Fortitude Family Office’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$127	Buy	+28	New	+$111	﹤0.01%	2153

Other funds holding TLSI

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Hoertkorn Richard Charles $149M AUM 77.22% 1-Year Est. Return

Ritter Daniher Financial Advisory Cincinnati, Ohio $657M AUM 20.27% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fortitude Family Office's TLSI Position: Q2 2026 in Review

Fortitude Family Office opened a new position in TriSalus Life Sciences (TLSI) in Q2 2026: 28 shares worth $127. The stake represents ﹤0.01% of the portfolio and ranks #2153 among its holdings.

12 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

Fortitude Family Office held 28 shares of TriSalus Life Sciences worth $127 as of Q2 2026.
TriSalus Life Sciences was a new Fortitude Family Office position in Q2 2026.
TriSalus Life Sciences made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #2153 holding.
12 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.